Hydroxychloroquine is “useless” against Covid-19: Oxford Professor


Team Udayavani, Jun 7, 2020, 12:57 PM IST

UK has halted a major drug trial after British scientists found that the anti-malarial hydroxychloroquine, was “useless” at treating Covid- 19 patients

The trial run by the University of Oxford has stopped enrolling patients with immediate effect saying “hydroxychloroquine does not benefit hospitalised Covid-19 patients” and “it did not reduce the risk of death.”

The Chief Investigators of the Randomised Evaluation of Covid-19 Therapy (RECOVERY) trial in UK, said a total of 1542 patients were randomised to hydroxychloroquine and compared with 3132 patients who were on usual care.

There was no significant difference in mortality benefits of those who took HCQ and those who did not.

Martin Landray, an Oxford University professor who is co-leading the RECOVERY trial, said, “This is not a treatment for COVID-19. It doesn’t work. This result should change medical practice worldwide. We can now stop using a drug that is useless.”

Earlier, Lancet raised safety concerns which led several Covid-19 studies of it to be halted. However, the Lancet study was then retracted on Thursday after its authors said they were unsure about its data.

But now the preliminary results from RECOVERY are quite clear and states that hydroxychloroquine does not reduce the risk of death among hospitalised patients with Covid-19.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

PM Modi arrives in Japan to attend former premier Abe’s state funeral

Akasa Air to start services to Guwahati, Agartala from Bengaluru

India cricketer Taniya Bhatia claims she was robbed in London hotel

CBI seeks more time to file objection in D K Shivakumar case

Bal Thackeray’s old-time assistant Champa Singh Thapa joins Eknath Shinde camp

India should make efforts to be among global leaders in fourth industrial revolution: President

Social media has never been a bad place for me: Hrithik Roshan


Related Articles More

New COVID-like virus found in bats could infect humans, resist vaccines: Study

Why are sugary drinks still sold in schools?

Nightmares are a good predictor of future dementia – new study

COVID-19 infection increases risk of long-term brain problems: Study

COVID-19 can cause lasting lung damage – 3 ways long COVID patients’ respiration can suffer

MUST WATCH

Kollur Mookambika

President Draupadi murmu inaugurates Mysore Dasara-2022

Creative PU College Moodabidri

Lighiting at Uchila Mahalakshmi Temple

Health Minister K Sudhakar Statement about paycm


Latest Additions

PM Modi arrives in Japan to attend former premier Abe’s state funeral

Akasa Air to start services to Guwahati, Agartala from Bengaluru

India cricketer Taniya Bhatia claims she was robbed in London hotel

CBI seeks more time to file objection in D K Shivakumar case

Bal Thackeray’s old-time assistant Champa Singh Thapa joins Eknath Shinde camp

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.